News & analysis, rated.
Breaking AI developments, in-depth guides, real-world case studies, and analysis — each one rated so you know what matters.
Cytomos Labels-Free Cell Analytics Cut CAR T Process Time 30%
Cytomos' AuraCyt platform uses single-cell physics to predict bioprocess outcomes without fluorescent tags. Three documented wins: 40% faster cell line development, 65% resource savings in lentivirus production, 30% reduction in CAR T timelines.
India hits 5 lakh organ donation pledges via Aadhaar portal
India's organ donation pledge registry crossed 500,000 registrations via its Aadhaar-linked platform. The milestone reflects a sustained push by health officials and media campaigns to close the transplant demand gap.
74 genetic variants linked to anxiety, 39 newly found
King's College London researchers identified 74 genome locations tied to anxiety symptoms in a study of 693,869 people. Genetics explain only 6% of severity differences, leaving room for environment and intervention.
90 minutes of lifting per week cuts death risk 13%, study finds
A 30-year study of 150,000 health workers found strength training 1.5–2 hours weekly lowered all-cause mortality by 13%, with bigger gains against heart disease and dementia when paired with aerobic exercise.
Sanofi swaps R&D leadership as Merck's immune drug clears pivotal test
Houman Ashrafian is leaving Sanofi for a new role. Meanwhile, Merck's Prometheus program succeeded in a pivotal study, and a psychedelics biotech saw shares surge. What changed in the biotech pipeline this week.
FDA reverses gene therapy rejection, Regenxbio moves to resubmit
The FDA is unwinding rejections from the Makary era that contradicted prior agreements with drugmakers. Regenxbio's Hunter syndrome therapy is the latest to get a path forward.
Eli Lilly cuts 340B hospital discounts over paperwork rules
Eli Lilly stopped honoring 340B drug pricing discounts for hospitals that failed to meet new documentation requirements. Hospitals are now asking the federal agency HRSA to intervene.
FDA warns of bleeding risk in Impella heart pump catheters
J&J's Abiomed and Oscor issued an early alert on devices that introduce catheters during Impella procedures. Clinicians should know the risk profile before your next case.
Abbott, PercuSense, Biolinq race to add glucose + other biomarkers to wearable sensors
Three diabetes device makers outline plans for multi-analyte sensors that measure glucose alongside lactate, ketones, or electrolytes. What's actually shipping and what remains in development.
Karl Storz cuts North Carolina jobs, exits Senhance robot line
Karl Storz is retiring the Asensus brand and Senhance surgical robot as part of a broader organizational restructuring. What the company's robotics pivot means for its installed base.
Eli Lilly cuts 340B discounts to hospitals over paperwork rules
Eli Lilly stopped honoring 340B drug discounts for non-compliant hospitals last week. Hospital groups are now pushing the federal agency HRSA to intervene in the pricing dispute.
Health M&A deal count drops in 2026 despite rising values
Deal volume fell as healthcare buyers grew cautious on reimbursement policy. But total deal value rose versus H1 2025. Here's what PwC found.